Atara Biotherapeutics, Inc. - Common Stock (ATRA)
CUSIP: 046513107
Q3 2018 13F Holders as of 30 Sep 2018
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 8,165,808
- Total 13F shares
- 46,348,347
- Share change
- -103,791
- Total reported value
- $1,916,490,444
- Put/Call ratio
- 202%
- Price per share
- $41.35
- Number of holders
- 114
- Value change
- -$3,168,582
- Number of buys
- 55
- Number of sells
- 47
Quarterly Holders Quick Answers
What is CUSIP 046513107?
CUSIP 046513107 identifies ATRA - Atara Biotherapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 046513107:
Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q3 2018
As of 30 Sep 2018,
Atara Biotherapeutics, Inc. - Common Stock (ATRA) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,348,347 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, FMR LLC, Redmile Group, LLC, BlackRock Inc., Vanguard Group Inc, BRIDGER MANAGEMENT, LLC, STATE STREET CORP, MORGAN STANLEY, PRICE T ROWE ASSOCIATES INC /MD/, and EAGLE ASSET MANAGEMENT INC.
This page lists
114
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2018 vs Q2 2018 Across Filers
Q2 2018 holders
122
Q3 2018 holders
114
Holder diff
-8
| Investor | Q2 2018 Shares | Q3 2018 Shares | Share Diff | Share Chg % | Q2 2018 Value $ | Q3 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.